CLAIMBOUND / SOURCE-PUBLICATION EVIDENCE
Pharmaceuticals
Every card identifies what it proves, what it does not prove, its exact quote, locator, source hash, and local rerun command.
1. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 3
Narrow public claim
The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) has the mission of achieving greater regulatory harmonization worldwide to ensure that safe, effective, and high-quality medicines are developed, registered, and maintained in the most resource-efficient manner.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 3- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t01_primary_claims.json --source-file <local-raw-pdf>Exact source quote
The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) has the mission of achieving greater regulatory harmonization worldwide to ensure that safe, effective, and high-quality medicines are developed, registered, and maintained in the most resource-efficient manner.2. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 3
Narrow public claim
By harmonizing the regulatory expectations in regions around the world, ICH guidelines have substantially reduced duplicative clinical studies, prevented unnecessary animal studies, standardized safety reporting and marketing application submissions, and contributed to many other improvements in the quality of global drug development and manufacturing and the products available to patients.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 3- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t01_primary_claims.json --source-file <local-raw-pdf>Exact source quote
By harmonizing the regulatory expectations in regions around the world, ICH guidelines have substantially reduced duplicative clinical studies, prevented unnecessary animal studies, standardized safety reporting and marketing application submissions, and contributed to many other improvements in the quality of global drug development and manufacturing and the products available to patients.3. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 3
Narrow public claim
ICH is a consensus-driven process that involves technical experts from regulatory authorities and industry parties in detailed technical and science-based harmonization work that results in the development of ICH guidelines.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 3- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t01_primary_claims.json --source-file <local-raw-pdf>Exact source quote
ICH is a consensus-driven process that involves technical experts from regulatory authorities and industry parties in detailed technical and science-based harmonization work that results in the development of ICH guidelines.4. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 6
Narrow public claim
Risk management principles are effectively utilized in many areas of business and government including finance, insurance, occupational safety, public health, pharmacovigilance, and by agencies regulating these industries.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 6- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t01_primary_claims.json --source-file <local-raw-pdf>Exact source quote
Risk management principles are effectively utilized in many areas of business and government including finance, insurance, occupational safety, public health, pharmacovigilance, and by agencies regulating these industries.5. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 6
Narrow public claim
In the pharmaceutical sector, the principles and framework of ICH Q9, coupled with the official ICH training material that supports this guideline, are instrumental in enhancing the application of effective quality risk management by industry and regulators.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 6- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t01_primary_claims.json --source-file <local-raw-pdf>Exact source quote
In the pharmaceutical sector, the principles and framework of ICH Q9, coupled with the official ICH training material that supports this guideline, are instrumental in enhancing the application of effective quality risk management by industry and regulators.6. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 6
Narrow public claim
The importance of quality systems has been recognized in the pharmaceutical industry and it is evident that quality risk management is a valuable component of an effective quality system.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 6- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t01_primary_claims.json --source-file <local-raw-pdf>Exact source quote
The importance of quality systems has been recognized in the pharmaceutical industry and it is evident that quality risk management is a valuable component of an effective quality system.7. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 6
Narrow public claim
It is commonly understood that risk is defined as the combination of the probability of occurrence of harm and the severity of that harm.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 6- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t01_primary_claims.json --source-file <local-raw-pdf>Exact source quote
It is commonly understood that risk is defined as the combination of the probability of occurrence of harm and the severity of that harm.8. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 7
Narrow public claim
An effective quality risk management approach can further ensure the quality of the drug (medicinal) product to the patient by providing a proactive means to identify and control potential quality issues during development, manufacturing, and distribution.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 7- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t01_primary_claims.json --source-file <local-raw-pdf>Exact source quote
An effective quality risk management approach can further ensure the quality of the drug (medicinal) product to the patient by providing a proactive means to identify and control potential quality issues during development, manufacturing, and distribution.9. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 7
Narrow public claim
This includes an appropriate application of root cause analysis that can identify and address the root cause(s) and other causal factors (e.g., human-related) of such issues.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 7- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t01_primary_claims.json --source-file <local-raw-pdf>Exact source quote
This includes an appropriate application of root cause analysis that can identify and address the root cause(s) and other causal factors (e.g., human-related) of such issues.10. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 7
Narrow public claim
A proactive approach to quality risk management is beneficial, as it facilitates robust product design and continual improvement, and it is of strategic importance in achieving an effective pharmaceutical quality system (see the International Council for Harmonisation (ICH) guidance for industry Q10 Pharmaceutical Quality System (ICH Q10) (April 2009)3 for guidance in relation to an effective pharmaceutical quality system).
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 7- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t01_primary_claims.json --source-file <local-raw-pdf>Exact source quote
A proactive approach to quality risk management is beneficial, as it facilitates robust product design and continual improvement, and it is of strategic importance in achieving an effective pharmaceutical quality system (see the International Council for Harmonisation (ICH) guidance for industry Q10 Pharmaceutical Quality System (ICH Q10) (April 2009)3 for guidance in relation to an effective pharmaceutical quality system).11. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 7
Narrow public claim
In the development phase and as part of validation, quality risk management is part of building knowledge and understanding risk scenarios, so that appropriate risk control can be decided upon for use during the commercial manufacturing phase.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 7- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t02_primary_claims.json --source-file <local-raw-pdf>Exact source quote
In the development phase and as part of validation, quality risk management is part of building knowledge and understanding risk scenarios, so that appropriate risk control can be decided upon for use during the commercial manufacturing phase.12. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 8
Narrow public claim
An understanding of formality can also support risk-based decision-making, where the level of formality that is applied may reflect the degree of importance of the decision, as well as the level of uncertainty and complexity which may be present.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 8- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t02_primary_claims.json --source-file <local-raw-pdf>Exact source quote
An understanding of formality can also support risk-based decision-making, where the level of formality that is applied may reflect the degree of importance of the decision, as well as the level of uncertainty and complexity which may be present.13. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 8
Narrow public claim
Appropriate use of quality risk management can facilitate but does not obviate industry’s obligation to comply with regulatory requirements and does not replace appropriate communications between industry and regulators.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 8- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t02_primary_claims.json --source-file <local-raw-pdf>Exact source quote
Appropriate use of quality risk management can facilitate but does not obviate industry’s obligation to comply with regulatory requirements and does not replace appropriate communications between industry and regulators.14. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 8
Narrow public claim
Quality risk management should not be used in a manner where decisions are made that justify a practice that would otherwise, in accordance with regulations and/or guidance, be deemed unacceptable.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 8- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t02_primary_claims.json --source-file <local-raw-pdf>Exact source quote
Quality risk management should not be used in a manner where decisions are made that justify a practice that would otherwise, in accordance with regulations and/or guidance, be deemed unacceptable.15. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 8
Narrow public claim
Instead, guidances describe the Agency’s current thinking on a topic and should be viewed only as recommendations, unless specific regulatory or statutory requirements are cited.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 8- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t02_primary_claims.json --source-file <local-raw-pdf>Exact source quote
Instead, guidances describe the Agency’s current thinking on a topic and should be viewed only as recommendations, unless specific regulatory or statutory requirements are cited.16. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 9
Narrow public claim
These decisions might be to return to the previous step and seek further information, to adjust the risk models or even to terminate the risk management process based upon information that supports such a decision.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 9- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t02_primary_claims.json --source-file <local-raw-pdf>Exact source quote
These decisions might be to return to the previous step and seek further information, to adjust the risk models or even to terminate the risk management process based upon information that supports such a decision.17. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 9
Narrow public claim
Responsibilities (4.1) Quality risk management activities are usually, but not always, undertaken by interdisciplinary teams.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 9- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t02_primary_claims.json --source-file <local-raw-pdf>Exact source quote
Responsibilities (4.1) Quality risk management activities are usually, but not always, undertaken by interdisciplinary teams.18. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 9
Narrow public claim
When teams are formed, they should include experts from the appropriate areas (e.g., quality unit, product development, business development, engineering, regulatory affairs, production operations, sales and marketing, supply chain, legal, statistics and clinical) in addition to individuals who are knowledgeable about the quality risk management process.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 9- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t02_primary_claims.json --source-file <local-raw-pdf>Exact source quote
When teams are formed, they should include experts from the appropriate areas (e.g., quality unit, product development, business development, engineering, regulatory affairs, production operations, sales and marketing, supply chain, legal, statistics and clinical) in addition to individuals who are knowledgeable about the quality risk management process.19. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 10
Narrow public claim
Initiating a Quality Risk Management Process (4.2) Quality risk management should include systematic processes designed to coordinate, facilitate and improve science-based decision-making with respect to risk.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 10- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t02_primary_claims.json --source-file <local-raw-pdf>Exact source quote
Initiating a Quality Risk Management Process (4.2) Quality risk management should include systematic processes designed to coordinate, facilitate and improve science-based decision-making with respect to risk.20. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 10
Narrow public claim
When the risk in question is well defined, an appropriate risk management tool (see examples in section V (5)) and the types of information needed to address the risk question will be more readily identifiable.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 10- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t02_primary_claims.json --source-file <local-raw-pdf>Exact source quote
When the risk in question is well defined, an appropriate risk management tool (see examples in section V (5)) and the types of information needed to address the risk question will be more readily identifiable.21. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 10
Narrow public claim
Hazard identification is a systematic use of information to identify hazards referring to the risk question or problem description.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 10- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t03_primary_claims.json --source-file <local-raw-pdf>Exact source quote
Hazard identification is a systematic use of information to identify hazards referring to the risk question or problem description.22. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 11
Narrow public claim
In doing an effective risk assessment, the robustness of the data set is important because it determines the quality of the output.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 11- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t03_primary_claims.json --source-file <local-raw-pdf>Exact source quote
In doing an effective risk assessment, the robustness of the data set is important because it determines the quality of the output.23. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 11
Narrow public claim
Revealing assumptions and reasonable sources of uncertainty will enhance confidence in this output and/or help identify its limitations.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 11- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t03_primary_claims.json --source-file <local-raw-pdf>Exact source quote
Revealing assumptions and reasonable sources of uncertainty will enhance confidence in this output and/or help identify its limitations.24. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 11
Narrow public claim
The output of a risk assessment is either a quantitative estimate of risk or a qualitative description of a range of risk.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 11- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t03_primary_claims.json --source-file <local-raw-pdf>Exact source quote
The output of a risk assessment is either a quantitative estimate of risk or a qualitative description of a range of risk.25. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 11
Narrow public claim
Alternatively, risk can be expressed using qualitative descriptors, such as “high,” “medium,” or “low,” which should be defined in as much detail as possible.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 11- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t03_primary_claims.json --source-file <local-raw-pdf>Exact source quote
Alternatively, risk can be expressed using qualitative descriptors, such as “high,” “medium,” or “low,” which should be defined in as much detail as possible.26. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 12
Narrow public claim
Processes that improve the detectability of hazards and quality risks might also be used as part of a risk control strategy.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 12- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t03_primary_claims.json --source-file <local-raw-pdf>Exact source quote
Processes that improve the detectability of hazards and quality risks might also be used as part of a risk control strategy.27. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 12
Narrow public claim
The implementation of risk reduction measures can introduce new risks into the system or increase the significance of other existing risks.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 12- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t03_primary_claims.json --source-file <local-raw-pdf>Exact source quote
The implementation of risk reduction measures can introduce new risks into the system or increase the significance of other existing risks.28. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 12
Narrow public claim
Hence, it might be appropriate to revisit the risk assessment to identify and evaluate any possible change in risk after implementing a risk reduction process.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 12- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t03_primary_claims.json --source-file <local-raw-pdf>Exact source quote
Hence, it might be appropriate to revisit the risk assessment to identify and evaluate any possible change in risk after implementing a risk reduction process.29. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 12
Narrow public claim
Risk Communication (4.5) Risk communication is the sharing of information about risk and risk management between the decision makers and others.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 12- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t03_primary_claims.json --source-file <local-raw-pdf>Exact source quote
Risk Communication (4.5) Risk communication is the sharing of information about risk and risk management between the decision makers and others.30. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 13
Narrow public claim
While detectability may not be a discrete factor in some quality risk management methods, detection controls are important as they can reduce the probability of occurrence of harm.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 13- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t03_primary_claims.json --source-file <local-raw-pdf>Exact source quote
While detectability may not be a discrete factor in some quality risk management methods, detection controls are important as they can reduce the probability of occurrence of harm.31. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 13
Narrow public claim
Traditionally, risks to quality have been assessed and managed in a variety of ways (empirical and/or internal procedures) based on, for example, compilation of observations, trends, and other information.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 13- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t04_primary_claims.json --source-file <local-raw-pdf>Exact source quote
Traditionally, risks to quality have been assessed and managed in a variety of ways (empirical and/or internal procedures) based on, for example, compilation of observations, trends, and other information.32. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 13
Narrow public claim
Such approaches continue to provide useful information that might support topics such as handling of complaints, quality defects, deviations, and allocation of resources.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 13- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t04_primary_claims.json --source-file <local-raw-pdf>Exact source quote
Such approaches continue to provide useful information that might support topics such as handling of complaints, quality defects, deviations, and allocation of resources.33. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 13
Narrow public claim
Formality in Quality Risk Management (5.1) Formality in quality risk management is not a binary concept (i.e., formal/informal); varying degrees of formality may be applied during quality risk management activities, including when making risk-based decisions.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 13- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t04_primary_claims.json --source-file <local-raw-pdf>Exact source quote
Formality in Quality Risk Management (5.1) Formality in quality risk management is not a binary concept (i.e., formal/informal); varying degrees of formality may be applied during quality risk management activities, including when making risk-based decisions.34. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 14
Narrow public claim
Systematic approaches for acquiring, analyzing, storing, and disseminating scientific information are essential for generating knowledge, which in turn informs all quality risk management activities.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 14- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t04_primary_claims.json --source-file <local-raw-pdf>Exact source quote
Systematic approaches for acquiring, analyzing, storing, and disseminating scientific information are essential for generating knowledge, which in turn informs all quality risk management activities.35. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 14
Narrow public claim
Uncertainty may be reduced via effective knowledge management, which enables accumulated and new information (both internal and external) to be used to support risk-based decisions throughout the product lifecycle.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 14- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t04_primary_claims.json --source-file <local-raw-pdf>Exact source quote
Uncertainty may be reduced via effective knowledge management, which enables accumulated and new information (both internal and external) to be used to support risk-based decisions throughout the product lifecycle.36. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 14
Narrow public claim
Importance: The more important a risk-based decision may be in relation to product quality, the higher the level of formality that should be applied, and the greater the need to reduce the level of uncertainty associated with it.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 14- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t04_primary_claims.json --source-file <local-raw-pdf>Exact source quote
Importance: The more important a risk-based decision may be in relation to product quality, the higher the level of formality that should be applied, and the greater the need to reduce the level of uncertainty associated with it.37. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 14
Narrow public claim
Complexity: The more complex a process or subject area is to a quality risk management activity, the higher the level of formality that should be applied to assure product quality.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 14- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t04_primary_claims.json --source-file <local-raw-pdf>Exact source quote
Complexity: The more complex a process or subject area is to a quality risk management activity, the higher the level of formality that should be applied to assure product quality.38. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 15
Narrow public claim
Risk-Based Decision-Making (5.2) Risk-based decision-making is inherent in all quality risk management activities; it provides an essential foundation for decision makers in an organization.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 15- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t04_primary_claims.json --source-file <local-raw-pdf>Exact source quote
Risk-Based Decision-Making (5.2) Risk-based decision-making is inherent in all quality risk management activities; it provides an essential foundation for decision makers in an organization.39. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 15
Narrow public claim
Effective risk-based decisionmaking begins with determining the level of effort, formality and documentation that should be applied during the quality risk management process.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 15- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t04_primary_claims.json --source-file <local-raw-pdf>Exact source quote
Effective risk-based decisionmaking begins with determining the level of effort, formality and documentation that should be applied during the quality risk management process.40. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 15
Narrow public claim
The decisions made from quality risk management activities include those in relation to what hazards exist, the risks associated with those hazards, the risk controls required, the acceptability of the residual risk after risk controls, and the communication and review of quality risk management activities and outputs.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 15- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t04_primary_claims.json --source-file <local-raw-pdf>Exact source quote
The decisions made from quality risk management activities include those in relation to what hazards exist, the risks associated with those hazards, the risk controls required, the acceptability of the residual risk after risk controls, and the communication and review of quality risk management activities and outputs.41. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 15
Narrow public claim
(See section V.A (5.1) above for guidance on what constitutes formality in quality risk management.) Higher levels of formality in quality risk management may require higher levels of structure in relation to risk-based decision-making.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 15- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t05_primary_claims.json --source-file <local-raw-pdf>Exact source quote
(See section V.A (5.1) above for guidance on what constitutes formality in quality risk management.) Higher levels of formality in quality risk management may require higher levels of structure in relation to risk-based decision-making.42. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 16
Narrow public claim
Managing and Minimizing Subjectivity (5.3) Subjectivity can impact every stage of a quality risk management process, especially the identification of hazards and the estimation of probability of occurrence and severity of harm.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 16- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t05_primary_claims.json --source-file <local-raw-pdf>Exact source quote
Managing and Minimizing Subjectivity (5.3) Subjectivity can impact every stage of a quality risk management process, especially the identification of hazards and the estimation of probability of occurrence and severity of harm.43. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 16
Narrow public claim
While subjectivity cannot be completely eliminated from quality risk management activities, it may be controlled by addressing bias and assumptions, the proper use of quality risk management tools and maximizing the use of relevant data and sources of knowledge (see ICH Q10, section II.E.1 (1.6.1)).
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 16- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t05_primary_claims.json --source-file <local-raw-pdf>Exact source quote
While subjectivity cannot be completely eliminated from quality risk management activities, it may be controlled by addressing bias and assumptions, the proper use of quality risk management tools and maximizing the use of relevant data and sources of knowledge (see ICH Q10, section II.E.1 (1.6.1)).44. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 17
Narrow public claim
Training of both industry and regulatory personnel in quality risk management processes provides for greater understanding of decision-making processes and builds confidence in quality risk management outcomes.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 17- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t05_primary_claims.json --source-file <local-raw-pdf>Exact source quote
Training of both industry and regulatory personnel in quality risk management processes provides for greater understanding of decision-making processes and builds confidence in quality risk management outcomes.45. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 17
Narrow public claim
The Role of Quality Risk Management in Addressing Product Availability Risks Arising From Quality/Manufacturing Issues (6.1) Quality/manufacturing issues, including non-compliance with Good Manufacturing Practice (GMP), are a significant cause of product availability issues (e.g., product shortages).
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 17- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t05_primary_claims.json --source-file <local-raw-pdf>Exact source quote
The Role of Quality Risk Management in Addressing Product Availability Risks Arising From Quality/Manufacturing Issues (6.1) Quality/manufacturing issues, including non-compliance with Good Manufacturing Practice (GMP), are a significant cause of product availability issues (e.g., product shortages).46. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 18
Narrow public claim
When risk-based drug shortage prevention and mitigation activities are performed, the level of formality that is applied to those activities may vary (see section V.A (5.1)) and should be commensurate with the level of risk associated with a loss of availability of the product(s).
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 18- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t05_primary_claims.json --source-file <local-raw-pdf>Exact source quote
When risk-based drug shortage prevention and mitigation activities are performed, the level of formality that is applied to those activities may vary (see section V.A (5.1)) and should be commensurate with the level of risk associated with a loss of availability of the product(s).47. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 18
Narrow public claim
A successful manufacturing partnership is strengthened by appropriate communication and collaboration mechanisms (See section II.G (2.7) of ICH Q10).
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 18- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t05_primary_claims.json --source-file <local-raw-pdf>Exact source quote
A successful manufacturing partnership is strengthened by appropriate communication and collaboration mechanisms (See section II.G (2.7) of ICH Q10).48. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 20
Narrow public claim
Hazard Identification: The systematic use of information to identify potential sources of harm (hazards) referring to the risk question or problem description.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 20- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t05_primary_claims.json --source-file <local-raw-pdf>Exact source quote
Hazard Identification: The systematic use of information to identify potential sources of harm (hazards) referring to the risk question or problem description.49. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 20
Narrow public claim
Quality System: The sum of all aspects of a system that implements quality policy and ensures that quality objectives are met.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 20- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t05_primary_claims.json --source-file <local-raw-pdf>Exact source quote
Quality System: The sum of all aspects of a system that implements quality policy and ensures that quality objectives are met.50. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 21
Narrow public claim
Stakeholder: Any individual, group or organization that can affect, be affected by, or perceive itself to be affected by a risk.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 21- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t05_primary_claims.json --source-file <local-raw-pdf>Exact source quote
Stakeholder: Any individual, group or organization that can affect, be affected by, or perceive itself to be affected by a risk.51. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 21
Narrow public claim
For the purposes of this guideline, the primary stakeholders are the patient, healthcare professional, regulatory authority, and industry.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 21- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t06_primary_claims.json --source-file <local-raw-pdf>Exact source quote
For the purposes of this guideline, the primary stakeholders are the patient, healthcare professional, regulatory authority, and industry.52. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 24
Narrow public claim
Failure Mode Effects Analysis (FMEA) (I.2) FMEA (see IEC 60812) provides for an evaluation of potential failure modes for processes and their likely effect on outcomes and/or product performance.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 24- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t06_primary_claims.json --source-file <local-raw-pdf>Exact source quote
Failure Mode Effects Analysis (FMEA) (I.2) FMEA (see IEC 60812) provides for an evaluation of potential failure modes for processes and their likely effect on outcomes and/or product performance.53. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 24
Narrow public claim
Failure Mode, Effects, and Criticality Analysis (FMECA) (I.3) FMEA might be extended to incorporate an investigation of the degree of severity of the consequences, their respective probabilities of occurrence, and their detectability, thereby becoming a Failure Mode Effect and Criticality Analysis (FMECA; see IEC 60812).
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 24- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t06_primary_claims.json --source-file <local-raw-pdf>Exact source quote
Failure Mode, Effects, and Criticality Analysis (FMECA) (I.3) FMEA might be extended to incorporate an investigation of the degree of severity of the consequences, their respective probabilities of occurrence, and their detectability, thereby becoming a Failure Mode Effect and Criticality Analysis (FMECA; see IEC 60812).54. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 25
Narrow public claim
Fault Tree Analysis (FTA) (I.4) The FTA tool (see IEC 61025) is an approach that assumes failure of the functionality of a product or process.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 25- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t06_primary_claims.json --source-file <local-raw-pdf>Exact source quote
Fault Tree Analysis (FTA) (I.4) The FTA tool (see IEC 61025) is an approach that assumes failure of the functionality of a product or process.55. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 25
Narrow public claim
Hazard Analysis and Critical Control Points (HACCP) (I.5) HACCP is a systematic, proactive, and preventive tool for assuring product quality, reliability, and safety (see WHO Technical Report Series No 908, 2003 Annex 7).
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 25- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t06_primary_claims.json --source-file <local-raw-pdf>Exact source quote
Hazard Analysis and Critical Control Points (HACCP) (I.5) HACCP is a systematic, proactive, and preventive tool for assuring product quality, reliability, and safety (see WHO Technical Report Series No 908, 2003 Annex 7).56. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 26
Narrow public claim
Hazard Operability Analysis (HAZOP) (I.6) HAZOP (see IEC 61882) is based on a theory that assumes that risk events are caused by deviations from the design or operating intentions.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 26- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t06_primary_claims.json --source-file <local-raw-pdf>Exact source quote
Hazard Operability Analysis (HAZOP) (I.6) HAZOP (see IEC 61882) is based on a theory that assumes that risk events are caused by deviations from the design or operating intentions.57. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 26
Narrow public claim
Preliminary Hazard Analysis (PHA) (I.7) PHA is a tool of analysis based on applying prior experience or knowledge of a hazard or failure to identify future hazards, hazardous situations and events that might cause harm, as well as to estimate their probability of occurrence for a given activity, facility, product, or system.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 26- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t06_primary_claims.json --source-file <local-raw-pdf>Exact source quote
Preliminary Hazard Analysis (PHA) (I.7) PHA is a tool of analysis based on applying prior experience or knowledge of a hazard or failure to identify future hazards, hazardous situations and events that might cause harm, as well as to estimate their probability of occurrence for a given activity, facility, product, or system.58. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 26
Narrow public claim
The tool consists of: (1) the identification of the possibilities that the risk event happens; (2) the qualitative evaluation of the extent of possible injury or damage to health that could result; (3) a relative ranking of the hazard using a combination of severity and likelihood of occurrence; and (4) the identification of possible remedial measures.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 26- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t06_primary_claims.json --source-file <local-raw-pdf>Exact source quote
The tool consists of: (1) the identification of the possibilities that the risk event happens; (2) the qualitative evaluation of the extent of possible injury or damage to health that could result; (3) a relative ranking of the hazard using a combination of severity and likelihood of occurrence; and (4) the identification of possible remedial measures.59. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 27
Narrow public claim
It can be used for product, process, and facility design as well as to evaluate the types of hazards for the general product type, then the product class, and finally the specific product.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 27- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t06_primary_claims.json --source-file <local-raw-pdf>Exact source quote
It can be used for product, process, and facility design as well as to evaluate the types of hazards for the general product type, then the product class, and finally the specific product.60. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 27
Narrow public claim
Typically, hazards identified in the PHA are further assessed with other risk management tools such as those in this section.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 27- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t06_primary_claims.json --source-file <local-raw-pdf>Exact source quote
Typically, hazards identified in the PHA are further assessed with other risk management tools such as those in this section.61. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 28
Narrow public claim
This Annex is intended to identify potential uses of quality risk management principles and tools by industry and regulators.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 28- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t07_primary_claims.json --source-file <local-raw-pdf>Exact source quote
This Annex is intended to identify potential uses of quality risk management principles and tools by industry and regulators.62. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 28
Narrow public claim
However, the selection of particular risk management tools is completely dependent upon specific facts and circumstances.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 28- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t07_primary_claims.json --source-file <local-raw-pdf>Exact source quote
However, the selection of particular risk management tools is completely dependent upon specific facts and circumstances.63. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 29
Narrow public claim
Change Management/Change Control To manage changes based on knowledge and information accumulated in pharmaceutical development and during manufacturing; To evaluate the impact of the changes on the availability of the final product; To evaluate the impact on product quality of changes to the facility, equipment, material, manufacturing process or technical transfers; To determine appropriate actions preceding the implementation of a change, e.g., additional testing, (re)qualification, (re)validation or communication with regulators.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 29- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t07_primary_claims.json --source-file <local-raw-pdf>Exact source quote
Change Management/Change Control To manage changes based on knowledge and information accumulated in pharmaceutical development and during manufacturing; To evaluate the impact of the changes on the availability of the final product; To evaluate the impact on product quality of changes to the facility, equipment, material, manufacturing process or technical transfers; To determine appropriate actions preceding the implementation of a change, e.g., additional testing, (re)qualification, (re)validation or communication with regulators.64. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 31
Narrow public claim
Hygiene Aspects in Facilities To protect the product from environmental hazards, including chemical, microbiological, and physical hazards (e.g., determining appropriate clothing and gowning, hygiene concerns); To protect the environment (e.g., personnel, potential for cross-contamination) from hazards related to the product being manufactured.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 31- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t07_primary_claims.json --source-file <local-raw-pdf>Exact source quote
Hygiene Aspects in Facilities To protect the product from environmental hazards, including chemical, microbiological, and physical hazards (e.g., determining appropriate clothing and gowning, hygiene concerns); To protect the environment (e.g., personnel, potential for cross-contamination) from hazards related to the product being manufactured.65. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 32
Narrow public claim
Quality Risk Management as Part of Materials Management Assessment and Evaluation of Suppliers and Contract Manufacturers (II.5) To provide a comprehensive evaluation of suppliers and contract manufacturers (e.g., auditing, supplier quality agreements).
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 32- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t07_primary_claims.json --source-file <local-raw-pdf>Exact source quote
Quality Risk Management as Part of Materials Management Assessment and Evaluation of Suppliers and Contract Manufacturers (II.5) To provide a comprehensive evaluation of suppliers and contract manufacturers (e.g., auditing, supplier quality agreements).66. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 32
Narrow public claim
Quality Risk Management as Part of Production Validation (II.6) To identify the scope and extent of verification, qualification, and validation activities (e.g., analytical methods, processes, equipment, and cleaning methods); To determine the extent for follow-up activities (e.g., sampling, monitoring and re-validation); To distinguish between critical and non-critical process steps to facilitate design of a validation study.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 32- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t07_primary_claims.json --source-file <local-raw-pdf>Exact source quote
Quality Risk Management as Part of Production Validation (II.6) To identify the scope and extent of verification, qualification, and validation activities (e.g., analytical methods, processes, equipment, and cleaning methods); To determine the extent for follow-up activities (e.g., sampling, monitoring and re-validation); To distinguish between critical and non-critical process steps to facilitate design of a validation study.67. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 33
Narrow public claim
Quality Risk Management as Part of Laboratory Control and Stability Studies Out of Specification Results (II.7) To identify potential root causes and corrective actions during the investigation of out of specification results.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 33- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t07_primary_claims.json --source-file <local-raw-pdf>Exact source quote
Quality Risk Management as Part of Laboratory Control and Stability Studies Out of Specification Results (II.7) To identify potential root causes and corrective actions during the investigation of out of specification results.68. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 33
Narrow public claim
Quality Risk Management as Part of Supply Chain Control (II.9) Regarding product availability risks related to quality/manufacturing issues, product lifecycle oversight of the supply chain includes maintaining current knowledge of quality/manufacturing hazards and prioritizing efforts to manage such risks.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 33- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t07_primary_claims.json --source-file <local-raw-pdf>Exact source quote
Quality Risk Management as Part of Supply Chain Control (II.9) Regarding product availability risks related to quality/manufacturing issues, product lifecycle oversight of the supply chain includes maintaining current knowledge of quality/manufacturing hazards and prioritizing efforts to manage such risks.69. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 34
Narrow public claim
Manufacturing Facilities and Equipment To ensure that facility infrastructure and equipment are suitable and designed for robust manufacturing (this includes packaging and testing) (see Annex II.4); To establish facility and equipment maintenance programs that assure reliable facility and equipment performance; To ensure that the operational design of equipment is not vulnerable to human error; To obtain quality and efficiency gains through the utilization of digitalization, automation, isolation technology, and other innovations.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 34- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t07_primary_claims.json --source-file <local-raw-pdf>Exact source quote
Manufacturing Facilities and Equipment To ensure that facility infrastructure and equipment are suitable and designed for robust manufacturing (this includes packaging and testing) (see Annex II.4); To establish facility and equipment maintenance programs that assure reliable facility and equipment performance; To ensure that the operational design of equipment is not vulnerable to human error; To obtain quality and efficiency gains through the utilization of digitalization, automation, isolation technology, and other innovations.70. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 34
Narrow public claim
Supplier Oversight and Relationships To enhance review and monitoring activities (see section III.G (2.7) of ICH Q10) when substantial variability is identified in the quality and safety of supplied materials or in the services provided.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- FDA ICH Q9(R1) Quality Risk Management Guidance
- Section locator
PDF page 34- Captured
- 2026-08-11
- Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t07_primary_claims.json --source-file <local-raw-pdf>Exact source quote
Supplier Oversight and Relationships To enhance review and monitoring activities (see section III.G (2.7) of ICH Q10) when substantial variability is identified in the quality and safety of supplied materials or in the services provided.